Concepts (175)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Positron-Emission Tomography | 10 | 2021 | 312 | 1.730 |
Why?
|
| Radiology | 4 | 2023 | 127 | 1.670 |
Why?
|
| Fluorodeoxyglucose F18 | 9 | 2021 | 136 | 1.290 |
Why?
|
| Artificial Intelligence | 6 | 2023 | 297 | 1.080 |
Why?
|
| Multimodal Imaging | 8 | 2017 | 113 | 1.070 |
Why?
|
| Diagnostic Imaging | 3 | 2025 | 317 | 0.960 |
Why?
|
| Insurance, Health, Reimbursement | 1 | 2025 | 36 | 0.900 |
Why?
|
| Radiology Information Systems | 2 | 2021 | 26 | 0.860 |
Why?
|
| Magnetic Resonance Imaging | 8 | 2017 | 3869 | 0.850 |
Why?
|
| Positron Emission Tomography Computed Tomography | 3 | 2021 | 79 | 0.730 |
Why?
|
| Gastroparesis | 4 | 2024 | 65 | 0.710 |
Why?
|
| Workflow | 2 | 2021 | 135 | 0.710 |
Why?
|
| Referral and Consultation | 1 | 2025 | 574 | 0.690 |
Why?
|
| Burnout, Professional | 1 | 2023 | 130 | 0.680 |
Why?
|
| Tomography, X-Ray Computed | 9 | 2023 | 2205 | 0.670 |
Why?
|
| Intestinal Volvulus | 3 | 2025 | 40 | 0.660 |
Why?
|
| Radiography | 6 | 2024 | 824 | 0.620 |
Why?
|
| Child | 36 | 2025 | 25863 | 0.620 |
Why?
|
| Ultrasonography | 7 | 2025 | 999 | 0.610 |
Why?
|
| Decision Support Systems, Clinical | 1 | 2021 | 202 | 0.600 |
Why?
|
| Histiocytosis | 1 | 2017 | 19 | 0.550 |
Why?
|
| Lung Diseases | 1 | 2021 | 404 | 0.530 |
Why?
|
| Pandemics | 4 | 2022 | 1193 | 0.510 |
Why?
|
| Magnetic Resonance Spectroscopy | 2 | 2014 | 306 | 0.500 |
Why?
|
| Digestive System Abnormalities | 3 | 2025 | 39 | 0.500 |
Why?
|
| Radiopharmaceuticals | 9 | 2021 | 171 | 0.500 |
Why?
|
| Breast | 2 | 2014 | 218 | 0.490 |
Why?
|
| Hip Dislocation | 3 | 2024 | 33 | 0.460 |
Why?
|
| Whole Body Imaging | 1 | 2014 | 31 | 0.440 |
Why?
|
| Dyspepsia | 3 | 2024 | 103 | 0.400 |
Why?
|
| Ileal Diseases | 2 | 2024 | 26 | 0.400 |
Why?
|
| Radiologists | 3 | 2022 | 51 | 0.400 |
Why?
|
| Breast Neoplasms | 3 | 2014 | 2762 | 0.400 |
Why?
|
| Intestinal Obstruction | 2 | 2024 | 96 | 0.400 |
Why?
|
| Humans | 52 | 2025 | 133331 | 0.390 |
Why?
|
| Lymphoma | 1 | 2016 | 331 | 0.390 |
Why?
|
| Intussusception | 2 | 2024 | 55 | 0.390 |
Why?
|
| Scoliosis | 2 | 2024 | 143 | 0.380 |
Why?
|
| Hospitals, Pediatric | 4 | 2025 | 795 | 0.340 |
Why?
|
| Foreign Bodies | 2 | 2021 | 110 | 0.320 |
Why?
|
| Gastrointestinal Diseases | 2 | 2022 | 353 | 0.280 |
Why?
|
| Gastric Emptying | 3 | 2024 | 78 | 0.280 |
Why?
|
| Radiology Department, Hospital | 2 | 2020 | 25 | 0.270 |
Why?
|
| Enema | 2 | 2024 | 44 | 0.270 |
Why?
|
| Neuroblastoma | 2 | 2023 | 550 | 0.260 |
Why?
|
| Lung Neoplasms | 3 | 2023 | 1558 | 0.260 |
Why?
|
| Adolescent | 15 | 2025 | 20569 | 0.250 |
Why?
|
| Female | 22 | 2025 | 71482 | 0.220 |
Why?
|
| Retrospective Studies | 16 | 2025 | 17568 | 0.220 |
Why?
|
| Appendicitis | 2 | 2024 | 130 | 0.210 |
Why?
|
| Contrast Media | 4 | 2021 | 517 | 0.210 |
Why?
|
| Multiple Pulmonary Nodules | 1 | 2023 | 21 | 0.210 |
Why?
|
| Hip Dislocation, Congenital | 1 | 2023 | 23 | 0.200 |
Why?
|
| Carcinoma, Renal Cell | 2 | 2016 | 251 | 0.200 |
Why?
|
| Observer Variation | 1 | 2024 | 309 | 0.200 |
Why?
|
| Solitary Pulmonary Nodule | 1 | 2023 | 28 | 0.200 |
Why?
|
| Prospective Studies | 5 | 2024 | 6582 | 0.200 |
Why?
|
| Academic Medical Centers | 1 | 2025 | 335 | 0.200 |
Why?
|
| Circulating Tumor DNA | 1 | 2023 | 39 | 0.200 |
Why?
|
| Radiographic Image Interpretation, Computer-Assisted | 2 | 2023 | 53 | 0.200 |
Why?
|
| Child, Preschool | 10 | 2025 | 14872 | 0.190 |
Why?
|
| Natural Killer T-Cells | 1 | 2023 | 84 | 0.190 |
Why?
|
| Ganglioneuroblastoma | 1 | 2021 | 6 | 0.180 |
Why?
|
| Ganglioneuroma | 1 | 2021 | 18 | 0.180 |
Why?
|
| Reflex | 1 | 2021 | 35 | 0.180 |
Why?
|
| Pediatrics | 2 | 2021 | 1221 | 0.180 |
Why?
|
| Kidney Neoplasms | 2 | 2016 | 460 | 0.180 |
Why?
|
| Gastrointestinal Motility | 1 | 2021 | 56 | 0.170 |
Why?
|
| Thyroid Gland | 1 | 2021 | 117 | 0.170 |
Why?
|
| Teleradiology | 1 | 2020 | 6 | 0.170 |
Why?
|
| Neuroendocrine Tumors | 1 | 2021 | 59 | 0.170 |
Why?
|
| Nuclear Medicine | 1 | 2020 | 7 | 0.170 |
Why?
|
| Meals | 1 | 2020 | 61 | 0.170 |
Why?
|
| Fractures, Bone | 1 | 2022 | 211 | 0.170 |
Why?
|
| Multi-Institutional Systems | 1 | 2020 | 12 | 0.170 |
Why?
|
| Surveys and Questionnaires | 4 | 2024 | 3982 | 0.170 |
Why?
|
| Biological Transport | 1 | 2021 | 367 | 0.160 |
Why?
|
| Hospitals, Community | 1 | 2020 | 55 | 0.160 |
Why?
|
| Workload | 1 | 2021 | 150 | 0.160 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2021 | 237 | 0.160 |
Why?
|
| Acetabulum | 3 | 2024 | 18 | 0.160 |
Why?
|
| Brain Neoplasms | 2 | 2023 | 1406 | 0.160 |
Why?
|
| Stomach | 1 | 2021 | 236 | 0.160 |
Why?
|
| Child Health Services | 1 | 2020 | 88 | 0.150 |
Why?
|
| Burkitt Lymphoma | 1 | 2020 | 141 | 0.150 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 3 | 2014 | 154 | 0.150 |
Why?
|
| Infant | 9 | 2025 | 13241 | 0.150 |
Why?
|
| Radiography, Dual-Energy Scanned Projection | 1 | 2018 | 10 | 0.150 |
Why?
|
| Male | 16 | 2025 | 65576 | 0.150 |
Why?
|
| Hospitals | 1 | 2022 | 440 | 0.150 |
Why?
|
| Eating | 1 | 2020 | 393 | 0.140 |
Why?
|
| Neuroimaging | 1 | 2021 | 376 | 0.140 |
Why?
|
| Thyroid Neoplasms | 1 | 2021 | 260 | 0.140 |
Why?
|
| Pulmonary Circulation | 1 | 2018 | 122 | 0.140 |
Why?
|
| Radionuclide Imaging | 3 | 2021 | 149 | 0.130 |
Why?
|
| Software | 1 | 2021 | 732 | 0.120 |
Why?
|
| Amino Acid Metabolism, Inborn Errors | 1 | 2016 | 115 | 0.120 |
Why?
|
| Stomach Neoplasms | 1 | 2020 | 496 | 0.110 |
Why?
|
| Sensitivity and Specificity | 3 | 2025 | 2142 | 0.110 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2020 | 772 | 0.110 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2016 | 502 | 0.100 |
Why?
|
| Emergency Service, Hospital | 1 | 2021 | 1166 | 0.100 |
Why?
|
| Hip Joint | 2 | 2023 | 46 | 0.100 |
Why?
|
| Inflammation | 1 | 2021 | 1559 | 0.100 |
Why?
|
| Severity of Illness Index | 1 | 2020 | 3105 | 0.090 |
Why?
|
| Reproducibility of Results | 3 | 2024 | 3041 | 0.090 |
Why?
|
| Helicobacter Infections | 1 | 2020 | 1110 | 0.090 |
Why?
|
| Helicobacter pylori | 1 | 2020 | 1174 | 0.090 |
Why?
|
| Esophagus | 2 | 2021 | 218 | 0.080 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2014 | 612 | 0.080 |
Why?
|
| Epilepsy | 1 | 2017 | 897 | 0.080 |
Why?
|
| Adult | 6 | 2023 | 31674 | 0.070 |
Why?
|
| Societies, Medical | 2 | 2023 | 779 | 0.070 |
Why?
|
| Infant, Newborn | 3 | 2025 | 8630 | 0.070 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2013 | 1313 | 0.070 |
Why?
|
| Lung | 1 | 2014 | 1571 | 0.060 |
Why?
|
| Treatment Outcome | 4 | 2024 | 13103 | 0.060 |
Why?
|
| Necrosis | 1 | 2024 | 212 | 0.050 |
Why?
|
| Short Bowel Syndrome | 1 | 2024 | 66 | 0.050 |
Why?
|
| Osteotomy | 1 | 2023 | 42 | 0.050 |
Why?
|
| Image Enhancement | 2 | 2014 | 173 | 0.050 |
Why?
|
| Arthroscopy | 1 | 2023 | 45 | 0.050 |
Why?
|
| Radiation Dosage | 1 | 2023 | 147 | 0.050 |
Why?
|
| Young Adult | 3 | 2023 | 9920 | 0.050 |
Why?
|
| Cytotoxicity, Immunologic | 1 | 2023 | 271 | 0.050 |
Why?
|
| Nausea | 1 | 2022 | 87 | 0.050 |
Why?
|
| Vomiting | 1 | 2022 | 110 | 0.050 |
Why?
|
| Radioisotopes | 1 | 2021 | 34 | 0.040 |
Why?
|
| Constipation | 1 | 2022 | 128 | 0.040 |
Why?
|
| Bronchi | 1 | 2021 | 106 | 0.040 |
Why?
|
| Receptors, Peptide | 1 | 2021 | 54 | 0.040 |
Why?
|
| Biomarkers, Tumor | 2 | 2023 | 1693 | 0.040 |
Why?
|
| Thyroidectomy | 1 | 2021 | 112 | 0.040 |
Why?
|
| Quarantine | 1 | 2020 | 17 | 0.040 |
Why?
|
| Tertiary Care Centers | 1 | 2021 | 271 | 0.040 |
Why?
|
| Feasibility Studies | 1 | 2023 | 823 | 0.040 |
Why?
|
| Triage | 1 | 2021 | 148 | 0.040 |
Why?
|
| Efficiency, Organizational | 1 | 2020 | 62 | 0.040 |
Why?
|
| Intestines | 1 | 2024 | 599 | 0.040 |
Why?
|
| Abdominal Pain | 1 | 2022 | 314 | 0.040 |
Why?
|
| Longitudinal Studies | 1 | 2024 | 1513 | 0.040 |
Why?
|
| Iopamidol | 1 | 2018 | 5 | 0.040 |
Why?
|
| Iohexol | 1 | 2018 | 21 | 0.040 |
Why?
|
| Signal-To-Noise Ratio | 1 | 2018 | 43 | 0.040 |
Why?
|
| Ultrasonography, Interventional | 1 | 2020 | 207 | 0.040 |
Why?
|
| Diagnosis, Differential | 1 | 2024 | 1973 | 0.040 |
Why?
|
| Length of Stay | 1 | 2024 | 1393 | 0.040 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2023 | 964 | 0.030 |
Why?
|
| Computed Tomography Angiography | 1 | 2018 | 214 | 0.030 |
Why?
|
| Prevalence | 1 | 2024 | 2628 | 0.030 |
Why?
|
| Patient Care Team | 1 | 2021 | 578 | 0.030 |
Why?
|
| Sex Factors | 1 | 2020 | 1353 | 0.030 |
Why?
|
| Everolimus | 1 | 2016 | 51 | 0.030 |
Why?
|
| Cross-Sectional Studies | 1 | 2025 | 3731 | 0.030 |
Why?
|
| Immunotherapy, Adoptive | 1 | 2023 | 899 | 0.030 |
Why?
|
| Antineoplastic Agents | 2 | 2016 | 1849 | 0.030 |
Why?
|
| Sirolimus | 1 | 2016 | 239 | 0.030 |
Why?
|
| Gadolinium DTPA | 1 | 2014 | 49 | 0.030 |
Why?
|
| Health Services Accessibility | 1 | 2020 | 658 | 0.030 |
Why?
|
| Tyrosine | 1 | 2014 | 157 | 0.030 |
Why?
|
| Time Factors | 1 | 2024 | 6544 | 0.030 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2016 | 453 | 0.030 |
Why?
|
| Indoles | 1 | 2014 | 202 | 0.030 |
Why?
|
| Pyrroles | 1 | 2014 | 185 | 0.030 |
Why?
|
| Forecasting | 1 | 2014 | 374 | 0.020 |
Why?
|
| Quality of Life | 1 | 2022 | 2161 | 0.020 |
Why?
|
| Texas | 1 | 2020 | 3666 | 0.020 |
Why?
|
| Algorithms | 1 | 2018 | 1730 | 0.020 |
Why?
|
| Mutation | 1 | 2023 | 6343 | 0.020 |
Why?
|
| Postoperative Complications | 1 | 2021 | 3171 | 0.020 |
Why?
|
| Middle Aged | 2 | 2018 | 28977 | 0.020 |
Why?
|
| Mice | 1 | 2023 | 18936 | 0.020 |
Why?
|
| United States | 1 | 2020 | 11721 | 0.010 |
Why?
|
| Brain | 1 | 2014 | 3223 | 0.010 |
Why?
|
| Animals | 1 | 2023 | 36217 | 0.010 |
Why?
|